Myofibroblast-mediated mechanisms of pathological remodelling of the heart.
about
Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyMyofibroblasts: trust your heart and let fate decide.Cardiac fibrosis in myocardial infarction-from repair and remodeling to regenerationThe fibrosis-cell death axis in heart failureIschemia and reperfusion related myocardial inflammation: A network of cells and mediators targeting the cardiomyocyteEmerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial HypertensionMesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal DialysisTGF-β1-mediated differentiation of fibroblasts is associated with increased mitochondrial content and cellular respirationPathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?RhoA determines lineage fate of mesenchymal stem cells by modulating CTGF-VEGF complex in extracellular matrix.Computational modeling of cardiac fibroblasts and fibrosisMyocardial fibrosis in congenital and pediatric heart diseaseMyocardial fibrosis: biomedical research from bench to bedside.High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling.Direct intercellular communications dominate the interaction between adipose-derived MSCs and myofibroblasts against cardiac fibrosis.Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetesHigh molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodelingCurrent Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure.Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contractionMiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis.The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart.Effects of Total Flavone from Rhododendron simsii Planch. Flower on Postischemic Cardiac Dysfunction and Cardiac Remodeling in RatsCardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repairUpregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis.Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts.Pregnancy differentially regulates the collagens types I and III in left ventricle from rat heart.Exposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in rats.Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction.Upregulation of transforming growth factor-β signaling in a rat model of rotator cuff tears.Mesenchymal-endothelial transition contributes to cardiac neovascularization.Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis.Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle.High resolution systematic digital histological quantification of cardiac fibrosis and adipose tissue in phospholamban p.Arg14del mutation associated cardiomyopathy.Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF β-Smad signal pathway.Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in miceThe inflammatory response in myocardial injury, repair, and remodelling.Signal regulatory protein-α protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signalingTemporal and Molecular Analyses of Cardiac Extracellular Matrix Remodeling following Pressure Overload in Adiponectin Deficient MiceC1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform.Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis.
P2860
Q27024879-CFAFC34E-7ACB-4D8B-80DD-230D94A8733CQ27692541-D0D72691-3E89-4B39-8AE4-6E88B5EB253DQ28068468-03D443FD-B242-4996-B838-B07CB34C09FEQ28076570-C39138C3-EE49-4444-AF05-561B5A2034CDQ28084618-925E9408-597A-407C-BED5-CE020482279BQ28085007-79189FAC-C1B1-464D-97B5-EF684748FBE8Q28390104-BB0C86E2-8901-41D5-B108-B5E9CCB5B0E4Q28545823-1349523B-1E39-4CA9-BB91-6610694764D1Q30234828-41E1C144-0129-47FA-AB63-79CF64D53D1BQ30276897-37FB63C4-EC6E-4B1E-A432-DDD36838FBCEQ30278019-9FA93A7C-506C-450F-9820-F2E1449389D3Q30355582-46122F1B-34CA-472D-93D8-848DD2A32683Q30362840-F0ED8842-DF11-4637-A65C-6AE38A6BCD15Q30665262-1276AE70-ACDB-49BF-9639-B88B581362C7Q30667260-150F2F58-E08A-4F7F-B296-A84A6B35B1C5Q31132310-A9990739-B8D6-40D4-9621-958802849CE7Q31161236-B13CC317-5753-4A22-95AA-8974BEA4FDBDQ33595504-2ABEACFC-7E23-4F6C-BD0E-DE7EB845BE4BQ33648136-5A7716A3-6425-4FFC-9FA1-D88C84D7DDF2Q33731819-A8397FCD-F411-4F8F-A704-1A563C6EB79DQ33737254-72D4F7A3-ACD3-456A-AB47-56B9CDDD3625Q33823169-5575E89F-53B8-4759-9731-0F6A31B22D63Q33850239-1CE4E85A-26D8-4339-9E4D-DEBA7ABAD53CQ33877343-11BDD67C-8297-4D6B-B278-625267940C5FQ33890276-9E8579E5-9F79-46BE-96C1-38A59BA94FFAQ34039536-96EA9CD4-A1B4-4584-84F1-01833400BF97Q34072217-C470F66E-5F31-4CCD-8782-1780B8ADC165Q34336849-F473822B-24A4-43C2-B044-A0AB3D935471Q34344966-FF17A6F5-2A8B-40AF-9D88-B78BF8109E25Q34429225-8793CDA3-5C7F-4C33-B90C-95FEF00BD1CEQ34899171-E8C8E72F-886A-4926-93B0-1218BB0A133BQ35061221-87F4BF8E-1119-474F-B387-CD44858B80C0Q35147756-F5E04A67-009A-41BA-9648-C53C1A0505BEQ35172597-5F16BE5A-D680-4EDE-94F5-031736BC6E35Q35261976-0B297B8E-364A-4B53-91B1-74BCA10CA4AEQ35529656-6D62070E-7230-4144-9778-D6A8C19E09D6Q35576675-605A44B0-8833-427B-A194-170D67E05E5DQ35614083-64355566-40F0-45E9-801A-96F22690F5EDQ35622442-17C6F65F-3DBA-4AAF-9CA3-E2C0497EAAE4Q35640723-81D316C4-C4D7-45E2-8BE3-3E6241E6A251
P2860
Myofibroblast-mediated mechanisms of pathological remodelling of the heart.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Myofibroblast-mediated mechanisms of pathological remodelling of the heart.
@en
type
label
Myofibroblast-mediated mechanisms of pathological remodelling of the heart.
@en
prefLabel
Myofibroblast-mediated mechanisms of pathological remodelling of the heart.
@en
P2093
P2860
P1476
Myofibroblast-mediated mechanisms of pathological remodelling of the heart.
@en
P2093
Ivan C Gerling
Karl T Weber
Robert A Ahokas
Syamal K Bhattacharya
P2860
P356
10.1038/NRCARDIO.2012.158
P407
P577
2012-12-04T00:00:00Z